Immediate Impact
2 from Science/Nature 63 standout
Citing Papers
Pancreatic cancer
2025 Standout
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
Works of Hideyuki Ohshimo being referenced
A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA
2004
An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Hideyuki Ohshimo | 993 | 704 | 280 | 315 | 17 | 1.4k | |
| Kazuhiko Yonekura | 761 | 617 | 468 | 291 | 23 | 1.3k | |
| Yasushi Mitachi | 721 | 704 | 121 | 292 | 18 | 1.0k | |
| N. Schleucher | 789 | 601 | 591 | 353 | 32 | 1.6k | |
| Alice Chen | 1280 | 603 | 152 | 234 | 14 | 1.7k | |
| Ірина Давиденко | 797 | 576 | 392 | 280 | 31 | 1.6k | |
| P. Fidias | 855 | 947 | 301 | 165 | 39 | 1.2k | |
| Marie‐Pierre Galais | 766 | 649 | 234 | 422 | 38 | 1.3k | |
| M Nishida | 1190 | 372 | 186 | 242 | 14 | 1.4k | |
| M. E. Vega-Villegas | 931 | 542 | 146 | 269 | 17 | 1.2k | |
| Hao Yu | 755 | 556 | 262 | 160 | 26 | 1.1k |
All Works
Loading papers...